belongs to the group of medicament known as benzodiazepine. This group includes diazepam
or Valium and flurazepam
. Iktorivil enhances the effects of the GABA neurotransmitter, inhibiting activity in the brain
Adults and children with seizures, such as akinetic, petit mal, and myoclonus seizure, may take Iktorivil. It is also effective for relieving short-term anxiety symptoms
. This medicament can be used to complement other medicaments for seizure disorders.
Dosage of Iktorivil depends on the patient and the condition being treated. Adults suffering from seizures take 1.5 milligrams three times a day. The dosage can be increased up to 1 milligram daily until the seizures are controlled. For patients with panic disorders the initial dosage is .25 milligrams twice a day. The dosage can be increased up to 1 milligram a day after 3 days.
The most common side effect is sedation. About half the patients taking Iktorivil experience sedation, while 1/3 experience dizziness
, unsteadiness, and weakness. Other side effects include cephalalgia, difficulty in sleeping, loss of orientation and unipolar disorder.
Iktorivil can result in physical dependence, which is typical with benzodiazepines. Patients who suddenly stop taking the medicament may feel side effects that include insomnia
and agitation. Patients taking Iktorivil for a longer period than prescribed may experience muscle cramping, seizure, vomiting
, and sweating.
Like most antiepileptic medicaments, Iktorivil results in an increased risk of patients having a suicidal behavior. Patients who use Iktorivil should balance
the risk with the clinical requirement for antiepileptic medicament.
Iktorivil heightens the effects of medicaments that slow down the brain processes including alcohol, narcotics, and barbiturates.
Pregnant women should not take Iktorivil since it has been linked to fetal damage especially in the first few months of the pregnancy. Most physicians discourage pregnant women from taking Iktorivil throughout their pregnancy.
Before taking Iktorivil, patients should tell their physicians if they have any allergy
especially to benzodiazepines such as lorazepam
and diazepam. Patients with liver
, medicament dependency, kidney
disease, breathing disorder, and mental disorder should discuss their condition with their physician before agreeing to take this medicament.
Taking Iktorivil may make a patient dizzy or drowsy, so be cautious when driving or operating machinery. The elderly are also more susceptible to the side effects of Iktorivil, most notably confusion
Iktorivil can have serious negative interactions with sodium oxybate. If a patient is taking this medicament, he or she must immediately inform their physician before beginning to take Iktorivil. Patients should tell their physician all of the medicaments - whether prescription or non-prescription - that they are taking.
Anti-depressants including fluoxetine
can interact negatively with Iktorivil. Other medicaments that cause drowsiness such as antihistamines, anti-anxiety, and anti-seizure medicaments may interact negatively with Iktorivil.
Iktorivil has the following structural formula:
• Molecular formula of iktorivil is C15H10ClN3O3
• Chemical IUPAC Name is 6-(2-chlorophenyl)-9-nitro-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-3-one
• Molecular weight is 315.711 g/mol
• Iktorivil available : 0.5mg tablets, 1mg tablets, 2mg tablets